This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit

Sponsored by Sequenom, Inc.

About this trial

Last updated 2 years ago

Study ID

SQNM-VIR-403

Status

Recruiting

Type

Observational [Patient Registry]

Placebo

No

Accepting

18-75 Years
2 to 89 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended a year ago

What is this trial about?

To compare the results obtained by analysis of a self-collected anterior nasal (AN) swab as part of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit to a healthcare provider (HCP)-collected AN swab in patients with symptoms of viral respiratory infection consistent with influenza A (Flu A), influenza B (Flu B), respiratory syncytial virus (RSV) and/or SARS-CoV-2 (C-19).

What are the participation requirements?

Yes

Inclusion Criteria

- presents with symptoms of viral respiratory infection consistent with Flu A, Flu B, RSV and/or C-19;

- Subject can read and understand written instructions in English; and

- Subject is able, in the professional opinion of the investigator, to provide up to 18.5mL of whole blood at the clinic visit. NOTE - the blood draw will be optional for subjects <12 years of age.

No

Exclusion Criteria

- no personal access to the internet and no email address

- Subject is 14-17 years of age and their parent or legal guardian is unable to supervise the collection of the AN swab sample from the subject;

- Subject is <14 years of age and their parent or legal guardian refuses to collect the AN swab sample from the subject; or

- Previous participation in this protocol.

Locations

Location

Status

Recruiting